HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng-Yun Wang Selected Research

Neoplasms (Cancer)

6/2018An efficient scheme for purification of a novel recombinant immunotoxin, rCCK8PE38, for anti-tumour experiments.
12/2017Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
12/2016Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population.
5/2016Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population.
1/2016A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population.
11/2015Genetic variations in the mTOR gene contribute toward gastric adenocarcinoma susceptibility in an Eastern Chinese population.
11/2014Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men.
11/2013Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.
10/2013Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
6/2013Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in eastern Chinese populations.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng-Yun Wang Research Topics

Disease

15Neoplasms (Cancer)
06/2018 - 01/2013
6Stomach Neoplasms (Stomach Cancer)
12/2016 - 07/2012
5Carcinogenesis
03/2017 - 03/2013
3Inflammation (Inflammations)
12/2016 - 03/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2015 - 03/2013
2Prostatic Neoplasms (Prostate Cancer)
11/2014 - 01/2013
1Renal Cell Carcinoma (Grawitz Tumor)
12/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2015
1Ovarian Epithelial Carcinoma
09/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2013
1Colorectal Neoplasms (Colorectal Cancer)
10/2013
1Esophageal Squamous Cell Carcinoma
06/2013
1Infections
03/2013
1Carcinoma (Carcinomatosis)
01/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2012
6Messenger RNA (mRNA)IBA
12/2017 - 07/2012
4MicroRNAs (MicroRNA)IBA
12/2017 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
05/2016 - 03/2013
2TOR Serine-Threonine KinasesIBA
11/2015 - 11/2013
2Caspase 7IBA
03/2015 - 01/2013
2Mechanistic Target of Rapamycin Complex 1IBA
11/2013 - 06/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2013 - 01/2012
1Immunotoxins (Immunotoxin)IBA
06/2018
1LDL Receptors (LDL Receptor)IBA
12/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2017
1oxidized low density lipoproteinIBA
12/2017
1Interleukin-17 (Interleukin 17)IBA
12/2016
1KinesinsIBA
09/2015
1AdiponectinIBA
11/2014
1alanylalanine (Ala-Ala)IBA
10/2013
1lysyllysine (Lys-Lys)IBA
10/2013
1valylvaline (Val-Val)IBA
10/2013
1Cisplatin (Platino)FDA LinkGeneric
04/2013
1PlatinumIBA
04/2013
1nedaplatinIBA
04/2013
1CytokinesIBA
03/2013
13' Untranslated Regions (3' UTR)IBA
01/2013
1NucleotidesIBA
01/2013